Gyoonhee Han

Title: Gyoonhee Han: Innovator in Pharmaceutical Chemistry

Introduction

Gyoonhee Han is a notable inventor based in Daejon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on innovative solutions for treating various health conditions, including asthma.

Latest Patents

Gyoonhee Han holds a patent for "Imidazopyrimidine derivatives and triazolopyrimidine derivatives." This patent describes a compound of the formula (I) where R is defined as OR, SR, SOR, NHR, or NRR, with R, R, and R being specified in detail. The compounds include various substituents such as H, C-Calkyl, carbamoyl, or ester groups. The patent also outlines a process for preparing these compounds, pharmaceutical compositions containing them, and methods for treating asthma using these innovative derivatives.

Career Highlights

Han is currently employed at Bayer Aktiengesellschaft, a leading global company in the pharmaceutical industry. His role involves extensive research and development, contributing to the advancement of new therapeutic agents. His expertise in chemical compounds has positioned him as a valuable asset in the field.

Collaborations

Gyoonhee Han has collaborated with esteemed colleagues, including Takeshi Yura and Arnel B Concepcion. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new pharmaceutical solutions.

Conclusion

Gyoonhee Han's contributions to pharmaceutical chemistry and his innovative patent for treating asthma highlight his role as a significant inventor in the industry. His work continues to impact the field positively, paving the way for future advancements in medical treatments.